Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID

Altimmune (ALT) Prices 3.37M Share Common Offering at $23/Sh

July 14, 2020 5:45 AM EDT

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 3,369,564 shares of its common stock and, to certain investors in lieu thereof, pre-funded warrants to purchase 1,630,436 shares of its common stock at an exercise price of $0.0001 per share. The public offering price of each share of common stock is $23.00 and the public offering price of each pre-funded warrant is $22.999 per underlying share. In addition, Altimmune has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at the... More

Altimmune (ALT) Plans Offering of Common Stock and Pre-Funded Warrants

July 13, 2020 4:01 PM EDT

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering and, to certain investors in lieu thereof, pre-funded warrants to purchase shares of its common stock. Altimmune also expects to grant the underwriters a 30-day option to... More